Natural Health Trends Corp. financials

NHTC CIK 0000912061

Source: EDGAR filings · Built 2026-06-02T03:39:32Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -6.07M -3.42M -4.32M -5.00M 791.00K 1.67M
EBITDA -1.70M -1.17M -1.51M -66.00K 1.87M 1.08M
Working Capital 20.51M 30.18M 44.24M 57.11M 68.81M 78.23M
Net Debt -4.81M -10.89M -52.71M -65.54M -80.68M -88.43M
Gross Margin 73.54% 73.98% 74.56% 74.23% 74.99% 72.63%
Operating Margin -4.55% -3.02% -3.80% -0.55% 2.62% 1.08%
Net Margin -2.22% 1.33% 1.29% 0.64% 1.81% 1.36%
Return on Equity (ROE) -3.76% 1.74% 1.37% 0.62% 1.82% 1.25%
Return on Assets (ROA) -2.30% 1.03% 0.82% 0.38% 1.10% 0.80%
Current Ratio 2.50× 2.45× 3.21× 3.79× 3.79× 4.64×
Debt-to-Equity 0.09× 0.08× 0.08× 0.08× 0.05× 0.06×
Effective Tax Rate -55.56% 7.74% 23.76% 48.01% 28.15% 43.42%
Cash Conversion Ratio 6.80× -5.89× -7.53× -15.50× 0.94× 2.24×
Accruals Ratio 0.13× 0.07× 0.07× 0.06× 0.00× -0.01×
SBC % of Revenue 0.33% 0.34% 0.37% 0.00%
CapEx Coverage -88.19× -59.07× -93.00× -33.93× 4.52× 8.93×
Free Cash Flow Per Share $-0.53 $-0.30 $-0.38 $-0.44 $0.07 $0.15

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 92.40× 117.20× 114.33× 75.11× 71.14×
P/FCF 97.69× 33.99×
FCF Yield 1.02% 2.94%
P/S 1008.31× 1395.73× 1731.61× 906.08× 1462.23× 1041.35×
P/B 1711.83× 1824.19× 1828.35× 887.71× 1474.93× 954.81×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 39.78M 42.96M 43.92M 49.13M 60.01M 62.07M
Cost of Goods and Services Sold 10.52M 11.18M 11.18M 12.66M 15.01M 16.99M
Gross Profit 29.25M 31.79M 32.75M 36.47M 44.99M 45.08M
Selling, General and Administrative Expense 14.76M 15.51M 16.01M 16.00M 17.85M 18.21M
Operating Expenses 31.06M 33.08M 34.42M 36.74M 43.42M 44.41M
Operating Income (Loss) -1.81M -1.30M -1.67M -270.00K 1.57M 669.00K
Income Tax Expense (Benefit) 315.00K 48.00K 177.00K 289.00K 425.00K 647.00K
Net Income (Loss) Attributable to Parent -882.00K 572.00K 568.00K 313.00K 1.08M 843.00K
Earnings Per Share, Basic $-0.08 $0.05 $0.05 $0.03 $0.10 $0.08
Weighted Average Number of Shares Outstanding, Basic 11.50M 11.47M 11.44M 11.36M 11.02M 10.63M
Earnings Per Share, Diluted $-0.08 $0.05 $0.05 $0.03 $0.09 $0.07
Weighted Average Number of Shares Outstanding, Diluted 11.50M 11.49M 11.46M 11.42M 11.42M 11.42M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 6.81M 13.53M 56.18M 69.67M 83.84M 92.37M
Assets, Current 34.19M 50.98M 64.23M 77.55M 93.47M 99.74M
Assets 38.43M 55.36M 69.09M 82.82M 98.36M 105.94M
Liabilities, Current 13.69M 20.80M 19.98M 20.44M 24.66M 21.51M
Liabilities 15.00M 22.49M 27.49M 32.67M 38.87M 38.24M
Stockholders' Equity Attributable to Parent 23.43M 32.87M 41.60M 50.15M 59.49M 67.70M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -6.00M -3.37M -4.28M -4.85M 1.02M 1.89M
Payments to Acquire Property, Plant, and Equipment 68.00K 57.00K 46.00K 143.00K 225.00K 211.00K
Net Cash Provided by (Used in) Investing Activities 8.15M -30.07M -46.00K -143.00K -225.00K -211.00K
Payments for Repurchase of Common Stock 0
Payments of Dividends 9.21M 9.21M 9.21M 9.14M 9.14M 9.14M
Net Cash Provided by (Used in) Financing Activities -9.21M -9.21M -9.21M -9.14M -9.14M -9.14M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (NHTC CIK 0000912061), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

FSLY

FASTLY, INC.

PHAT

PHATHOM PHARMACEUTICALS, INC.

AIRT

AIR T, INC.